Chizu Nonomura

Shimonagakubo, 4118777, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.

Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.

Journal: Immunology letters
Published: October 29, 2018

Classification of tumor microenvironment immune types based on immune response-associated gene expression.

Classification of tumor microenvironment immune types based on immune response-associated gene expression.

Journal: International journal of oncology
Published: July 23, 2018

A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.

A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 23, 2017

Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysis.

Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysis.

Journal: Oncology reports
Published: August 22, 2017

Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.

Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.

Journal: The Journal of dermatology
Published: January 24, 2017

The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line.

The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line.

Journal: Immunology letters
Published: January 10, 2017

Multi-omics Profiling of Patients with Melanoma Treated with Nivolumab in Project HOPE.

Multi-omics Profiling of Patients with Melanoma Treated with Nivolumab in Project HOPE.

Journal: Anticancer research
Published: January 05, 2017

Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line.

Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line.

Journal: Cancer genomics & proteomics
Published: November 15, 2016

Immunological effects of the anti-programmed death-1 antibody on human peripheral blood mononuclear cells.

Immunological effects of the anti-programmed death-1 antibody on human peripheral blood mononuclear cells.

Journal: International journal of oncology
Published: April 15, 2016

Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.

Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.

Journal: Oncology reports
Published: April 12, 2016

Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.

Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2016
Showing 1-11 of 11

Last Updated: 09/26/2026